DRIPBaR Direct' is designed to provide The DRIPBaR's clients with convenient access to personalized health and wellness solutions from the comfort of their homes. Through the VSDHOne platform, clients ...

If your weight loss goals have taken a backward step, this simple device might be all you need to get back on track and shed ...

“Taking these medications puts individuals at risk of everything from allergic reactions to uncontrolled blood sugar levels, ...

The company sells tirzepatide, approved for weight loss under the name Zepbound ... selling the instruments and accessories ...

Tirzepatide was removed from the shortages list a few weeks ago, leading to restrictions on the sale of compounded versions. However, the FDA has launched a review to check if the shortages have ...

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.

FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

None ...

Leerink Partners analyst David Risinger maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on January 24 and set a price ...

Websites that sell compounded glucagon-like peptide-1 receptor agonists often partially inform or misinform consumers.

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...